The rapid rise in the use of GLP-1 receptor agonists is transforming the treatment of obesity and metabolic disease, but significant challenges remain regarding long-term adherence, sustaining health outcomes, and integrating treatment with lifestyle change. This panel will explore how effective support demands a longitudinal, personalized approach that integrates digital elements with real-world infrastructure.